Display options
Cite
Marcello M, Denham JW, Kennedy A, et al. Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials. Front Oncol. 2020;10:1174doi: 10.3389/fonc.2020.01174.
Marcello, M., Denham, J. W., Kennedy, A., Haworth, A., Steigler, A., Greer, P. B., Holloway, L. C., Dowling, J. A., Jameson, M. G., Roach, D., Joseph, D. J., Gulliford, S. L., Dearnaley, D. P., Sydes, M. R., Hall, E., & Ebert, M. A. (2020). Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials. Frontiers in oncology, 101174. https://doi.org/10.3389/fonc.2020.01174
Marcello, Marco, et al. "Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials." Frontiers in oncology vol. 10 (2020): 1174. doi: https://doi.org/10.3389/fonc.2020.01174
Marcello M, Denham JW, Kennedy A, Haworth A, Steigler A, Greer PB, Holloway LC, Dowling JA, Jameson MG, Roach D, Joseph DJ, Gulliford SL, Dearnaley DP, Sydes MR, Hall E, Ebert MA. Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials. Front Oncol. 2020 Jul 22;10:1174. doi: 10.3389/fonc.2020.01174. eCollection 2020. PMID: 32793485; PMCID: PMC7387667.
Copy Download .nbib Format: NLM
Share it on

Front Oncol. 2020 Jul 22;10:1174. doi: 10.3389/fonc.2020.01174. eCollection 2020.

Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials.

Frontiers in oncology

Marco Marcello, James W Denham, Angel Kennedy, Annette Haworth, Allison Steigler, Peter B Greer, Lois C Holloway, Jason A Dowling, Michael G Jameson, Dale Roach, David J Joseph, Sarah L Gulliford, David P Dearnaley, Matthew R Sydes, Emma Hall, Martin A Ebert

Affiliations

  1. Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
  2. Department of Physics, University of Western Australia, Perth, WA, Australia.
  3. School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.
  4. School of Physics, University of Sydney, Sydney, NSW, Australia.
  5. Prostate Cancer Trials Group, School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.
  6. School of Mathematical and Physical Sciences, University of Newcastle, Callaghan, NSW, Australia.
  7. Department of Radiation Oncology, Calvary Mater Newcastle, Waratah, NSW, Australia.
  8. Department of Medical Physics, Liverpool Cancer Centre, Liverpool, NSW, Australia.
  9. South Western Sydney Clinical School, University of New South Wales, Kensington, NSW, Australia.
  10. Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia.
  11. CSIRO, St Lucia, QLD, Australia.
  12. Cancer Research Team, Ingham Institute for Applied Medical Research, Liverpool, NSW, Australia.
  13. School of Surgery, University of Western Australia, Perth, WA, Australia.
  14. 5D Clinics, Claremont, WA, Australia.
  15. GenesisCare WA, Wembley, WA, Australia.
  16. Radiotherapy Department, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  17. Department of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom.
  18. Academic UroOncology Unit, The Institute of Cancer Research and the Royal Marsden NHS Trust, London, United Kingdom.
  19. MRC Clinical Trials Unit, Medical Research Council, London, United Kingdom.
  20. Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom.

PMID: 32793485 PMCID: PMC7387667 DOI: 10.3389/fonc.2020.01174

[No abstract available.]

Copyright © 2020 Marcello, Denham, Kennedy, Haworth, Steigler, Greer, Holloway, Dowling, Jameson, Roach, Joseph, Gulliford, Dearnaley, Sydes, Hall and Ebert.

Keywords: dose-toxicity relationships; external beam radiotherapy; prostate cancer; urinary toxicity; voxel-based analysis

References

  1. Lancet Oncol. 2014 Sep;15(10):1076-89 - PubMed
  2. Clin Anat. 2014 Nov;27(8):1275-83 - PubMed
  3. Radiother Oncol. 2016 Apr;119(1):123-8 - PubMed
  4. Asian J Androl. 2015 Sep-Oct;17(5):831-8 - PubMed
  5. Rev Urol. 2001;3 Suppl 1:S2-6 - PubMed
  6. Radiother Oncol. 2012 Nov;105(2):266-8 - PubMed
  7. Lancet Oncol. 2012 Jan;13(1):43-54 - PubMed
  8. Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):343-354 - PubMed
  9. Eur Urol. 2016 Dec;70(6):1032-1041 - PubMed
  10. Clin Transl Radiat Oncol. 2019 Dec 31;21:77-84 - PubMed
  11. Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1124-9 - PubMed
  12. Med Phys. 2019 May;46(5):2243-2250 - PubMed
  13. Neuroimage. 2009 Jan 1;44(1):83-98 - PubMed
  14. Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):420-426 - PubMed
  15. Urology. 2003 Feb;61(2 Suppl 1):32-8 - PubMed
  16. Radiother Oncol. 2015 Jun;115(3):301-7 - PubMed
  17. Clin Oncol (R Coll Radiol). 2018 Sep;30(9):539-547 - PubMed
  18. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1141-1147 - PubMed
  19. Lancet Oncol. 2014 Apr;15(4):464-73 - PubMed
  20. BJU Int. 2008 Jul;102(1):39-43 - PubMed
  21. Radiother Oncol. 2014 Jul;112(1):95-9 - PubMed
  22. Front Oncol. 2019 Mar 13;9:130 - PubMed
  23. Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):980-8 - PubMed
  24. Radiother Oncol. 2018 Feb;126(2):249-256 - PubMed
  25. PLoS One. 2017 Jun 22;12(6):e0179845 - PubMed
  26. Radiat Oncol. 2013 Dec 23;8:293 - PubMed
  27. Phys Med. 2016 Dec;32(12):1681-1689 - PubMed
  28. Radiother Oncol. 2015 Nov;117(2):277-82 - PubMed
  29. Radiother Oncol. 2017 Jun;123(3):466-471 - PubMed
  30. Radiother Oncol. 2014 Jul;112(1):140-4 - PubMed
  31. Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):267-84 - PubMed
  32. Radiother Oncol. 2006 Sep;80(3):355-62 - PubMed
  33. Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):339-44 - PubMed
  34. Ann Stat. 2013 Feb;41(1):196-220 - PubMed
  35. J Sex Med. 2011 Apr;8(4):1228-38 - PubMed
  36. World J Urol. 2014 Jun;32(3):743-51 - PubMed
  37. Radiother Oncol. 2008 Feb;86(2):200-10 - PubMed
  38. Clin Oncol (R Coll Radiol). 2011 Nov;23(9):613-24 - PubMed
  39. Int Neurourol J. 2012 Sep;16(3):102-6 - PubMed
  40. Lancet Oncol. 2007 Jun;8(6):475-87 - PubMed
  41. Neuroimage. 2006 Jul 1;31(3):1116-28 - PubMed
  42. Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1514-1532 - PubMed
  43. Radiother Oncol. 2004 Aug;72(2):199-211 - PubMed
  44. Radiother Oncol. 2015 Jul;116(1):112-8 - PubMed
  45. Aust Fam Physician. 2013 Mar;42(3):123-6 - PubMed
  46. Radiother Oncol. 2012 Nov;105(2):184-92 - PubMed
  47. Clin Transl Radiat Oncol. 2017 Oct 10;6:31-36 - PubMed
  48. Lancet Oncol. 2016 Aug;17(8):1047-1060 - PubMed
  49. Clin Oncol (R Coll Radiol). 2019 Sep;31(9):611-620 - PubMed
  50. Int J Radiat Oncol Biol Phys. 1995 Mar 30;31(5):1049-91 - PubMed

Publication Types

Grant support